Fund
Panakes Partners
Panakes Partners took part in the round of Nouscom (120 M€) on 19 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
Get Panakes Partners's next deals
An email each time this fund appears in a new health deal, plus the Friday newsletter. Nothing else.
Free. One click to unsubscribe. The list is never sold. In French.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 19 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 19 Oct | Switzerland, Biotech | Series D and later | 120 M€ | Participant |
Co investors 14 funds crossed
- 5AM Ventures 1 operation
- Andera Partners 1 operation
- Angelini Industries 1 operation
- Angelini Ventures 1 operation
- Banque européenne d'investissement 1 operation
- Bpifrance 1 operation
- CDP Venture Capital 1 operation
- EQT Life Sciences 1 operation
- Indaco Venture Partners 1 operation
- M Ventures 1 operation
- Neva SGR 1 operation
- Revelation Partners 1 operation
- Versant Ventures 1 operation
- XGEN Ventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: Switzerland.